Table of Contents Author Guidelines Submit a Manuscript
Pulmonary Medicine
Volume 2011, Article ID 845864, 13 pages
http://dx.doi.org/10.1155/2011/845864
Review Article

Diagnosis and Management of Pulmonary Arterial Hypertension

Division of Pulmonary, Sleep and Critical Care Medicine, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI 02903, USA

Received 16 January 2011; Accepted 6 June 2011

Academic Editor: Aldo T. Iacono

Copyright © 2011 Jeanne Houtchens et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [24 citations]

The following is the list of published articles that have cited the current article.

  • F. Blasi, “The challenge of breathlessness in the detection of pulmonary hypertension,” European Respiratory Review, vol. 21, no. 123, pp. 1–3, 2012. View at Publisher · View at Google Scholar
  • Cindy R. Miller, “Pulmonary veno-occlusive disease: a misnomer?,” Pediatric Radiology, vol. 42, no. 6, pp. 647–652, 2012. View at Publisher · View at Google Scholar
  • Aaron Waxman, Shih-Yin Chen, Luke Boulanger, Jay A. Watson, and Gil Golden, “Factors associated with adherence to phosphodiesterase type 5 inhibitors for the treatment of pulmonary arterial hypertension,” Journal of Medical Economics, vol. 16, no. 2, pp. 298–306, 2012. View at Publisher · View at Google Scholar
  • Keith Owen, David M. Cross, Mazin Derzi, Elizabeth Horsley, and Fiona L. Stavros, “An overview of the preclinical toxicity and potential carcinogenicity of sitaxentan (Thelin®), a potent endothelin receptor antagonist developed for pulmonary arterial hypertension,” Regulatory Toxicology and Pharmacology, vol. 64, no. 1, pp. 95–103, 2012. View at Publisher · View at Google Scholar
  • Natalie Sampson, Peter Berger, and Christoph Zenzmaier, “Therapeutic Targeting of Redox Signaling in Myofibroblast Differentiation and Age-Related Fibrotic Disease,” Oxidative Medicine And Cellular Longevity, 2012. View at Publisher · View at Google Scholar
  • Iraklis Tsangaris, Georgios Tsaknis, Anastasia Anthi, and Stylianos E. Orfanos, “Pulmonary Hypertension in Parenchymal Lung Disease,” Pulmonary Medicine, vol. 2012, pp. 1–14, 2012. View at Publisher · View at Google Scholar
  • Ayodeji Adegunsoye, and Siva Ramachandran, “Etiopathogenetic Mechanisms of Pulmonary Hypertension in Sleep-Related Breathing Disorders,” Pulmonary Medicine, vol. 2012, pp. 1–10, 2012. View at Publisher · View at Google Scholar
  • Roberto Poscia, Carmine Dario Vizza, Roberto Badagliacca, Mario Mezzapesa, Martina Nocioni, and Francesco Fedele, “Therapeutic strategies in pulmonary arterial hypertension,” European Cardiology, vol. 8, no. 3, pp. 198–203, 2012. View at Publisher · View at Google Scholar
  • John F. Kingrey, Ralph J. Panos, Jun Ying, Karthikeyan Meganathan, Robin Vandivier, and Jean M. Elwing, “Provider Recognition and Response to Echocardiographic Findings Indicating Pulmonary Hypertension in the Veterans Affairs Medical Center Population,” Pulmonary Circulation, vol. 3, no. 2, pp. 389–395, 2013. View at Publisher · View at Google Scholar
  • Sonata Jodele, Russel Hirsch, Benjamin Laskin, Stella Davies, David Witte, and Ranjit Chima, “Pulmonary Arterial Hypertension in Pediatric Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy,” Biology Of Blood And Marrow Transplantation, vol. 19, no. 2, pp. 202–207, 2013. View at Publisher · View at Google Scholar
  • Russel Hirsch, Ranjit Chima, Stella M. Davies, and Sonata Jodele, “Pulmonary Hypertension after Hematopoietic Stem Cell Transplantation,” Biology of Blood and Marrow Transplantation, vol. 19, no. 11, pp. 1546–1556, 2013. View at Publisher · View at Google Scholar
  • Omer Araz, Elif Yilmazel Ucar, Aslihan Yalcin, Didem Pulur, Hamit Acemoglu, Hakan Tas, Leyla Saglam, Metin Akgun, and Arzu Mirici, “The incidence and severity of pulmonary hypertension in obstructive sleep apnea with hypothyroidism,” Medical Science Monitor, vol. 19, no. 1, pp. 883–887, 2013. View at Publisher · View at Google Scholar
  • Giorgio Serino, Marco Guazzi, Angelo Micheletti, Carlo Lombardi, Rossella Danesi, Diana Negura, Mario Carminati, and Massimo Chessa, “Effect of bosentan on exercise capacity and clinical worsening in patients with dual Down and Eisenmenger syndrome,” Clinical Medicine Insights: Cardiology, vol. 7, pp. 29–34, 2013. View at Publisher · View at Google Scholar
  • Madhukar B. Kolli, Nandini D.P.K. Manne, Radhakrishna Para, Siva K. Nalabotu, Geeta Nandyala, Tolou Shokuhfar, Kun He, Azhang Hamlekhan, Jane Y. Ma, Paulette S. Wehner, Lucy Dornon, Ravikumar Arvapalli, Kevin M. Rice, and Eric R. Blough, “Cerium oxide nanoparticles attenuate monocrotaline induced right ventricular hypertrophy following pulmonary arterial hypertension,” Biomaterials, 2014. View at Publisher · View at Google Scholar
  • Jasper Vanhoof, Marion Delcroix, Ellen Vandevelde, Kris Denhaerynck, Wim Wuyts, Catharina Belge, and Fabienne Dobbels, “Emotional Symptoms and Quality of Life in Patients with Pulmonary Arterial Hypertension,” The Journal of Heart and Lung Transplantation, 2014. View at Publisher · View at Google Scholar
  • Sonata Jodele, Benjamin L. Laskin, Christopher E. Dandoy, Kasiani C. Myers, Javier El-Bietar, Stella M. Davies, Jens Goebel, and Bradley P. Dixon, “A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury,” Blood Reviews, 2014. View at Publisher · View at Google Scholar
  • Natalie Sampson, Peter Berger, and Christoph Zenzmaier, “Redox Signaling as a Therapeutic Target to Inhibit Myofibroblast Activation in Degenerative Fibrotic Disease,” BioMed Research International, vol. 2014, pp. 1–14, 2014. View at Publisher · View at Google Scholar
  • Marta Baranowska-Kuczko, Anna Pędzińska-Betiuk, Konrad Jackowski, Monika Kloza, and Hanna Kozlowska, “Serotonin hypothesis and pulmonary artery hypertension,” Postepy Higieny i Medycyny Doswiadczalnej, vol. 68, pp. 738–748, 2014. View at Publisher · View at Google Scholar
  • Derya Özyörük, Ayşe Esin Kibar, Murat Sürücü, Emine Azak, Suna Emir, İbrahim İlker Çetin, Bahattin Tunç, and Namık Yaşar Özbek, “Pulmonary arterial hypertension in a child with stage-IV neuroblastoma after autologous hematopoietic stem cell transplantation and review of the literature,” Pediatric Transplantation, 2015. View at Publisher · View at Google Scholar
  • Sonata Jodele, Christopher E Dandoy, Kasiani C Myers, Javier El-Bietar, Adam Nelson, Gregory Wallace, and Benjamin L Laskin, “New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy,” Transfusion and Apheresis Science, 2016. View at Publisher · View at Google Scholar
  • Dongmei Jiang, Yu Chen, Yuxiang Zhu, Guosheng Fu, and Shiming Xu, “Expression of key enzymes in the mevalonate pathway are altered in monocrotaline-induced pulmonary arterial hypertension in rats,” Molecular Medicine Reports, vol. 16, no. 6, pp. 9593–9600, 2017. View at Publisher · View at Google Scholar
  • Norris Lan, Benjamin Massam, Sandeep Kulkarni, and Chim Lang, “Pulmonary Arterial Hypertension: Pathophysiology and Treatment,” Diseases, vol. 6, no. 2, pp. 38, 2018. View at Publisher · View at Google Scholar
  • Fan Ma, Kaiyu Zhou, Yimin Hua, Xiaoliang Liu, Hongyu Duan, Yifei Li, and Chuan Wang, “Chronic thromboembolic pulmonary hypertension as the first manifestation of nephrotic syndrome in a 12-year-old child,” Medicine, vol. 97, no. 41, pp. e12349, 2018. View at Publisher · View at Google Scholar
  • Peter Noymer, Assaf Shaked, and Kay Newell, “Human factors and usability engineering in the development of SMT-101 for the treatment of pulmonary arterial hypertension,” Expert Opinion on Drug Delivery, pp. 1–9, 2018. View at Publisher · View at Google Scholar